How Is EGPA Distinguished From Severe Asthma and GPA?

Doctors distinguish EGPA from severe asthma and Granulomatosis with Polyangiitis (GPA) by looking for a specific clinical pattern. A classic presentation includes severe asthma, high levels of eosinophils (a type of white blood cell), and signs of vasculitis (inflammation of blood vessels) ^[1][2]. However, not everyone has all these features at once. Diagnosis is not based on a single test, but rather on integrating your symptom history, eosinophil counts, specific organ involvement, and laboratory testing ^[3].

While severe eosinophilic asthma shares the airway symptoms and high eosinophils, it does not involve systemic blood vessel inflammation ^[1]. Meanwhile, GPA is a related vasculitis that typically presents with a different pattern of organ damage and different autoantibodies, and it rarely involves severe asthma ^[4][5].

Telling EGPA Apart from Severe Eosinophilic Asthma

Severe eosinophilic asthma can look identical to the early, non-vasculitic phases of EGPA ^[1]. Severe asthma and chronic sinus issues often precede an EGPA diagnosis by years ^[1][6].

Because high eosinophils are not unique to EGPA, doctors must first rule out other mimics, such as drug reactions, parasitic infections, or other hypereosinophilic syndromes ^[3]. What shifts the probability toward EGPA is evidence that inflammation has moved beyond the airways to involve other organs:

• Nerve damage: Mononeuritis multiplex is a pattern of nerve injury that causes asymmetric numbness, tingling, or weakness (for example, a sudden foot drop or hand weakness), and it strongly supports a vasculitis diagnosis ^[2][7].
• Skin changes: Unexplained rashes, nodules, or purpura (purple spots from bleeding under the skin) are common in EGPA but not typical of asthma alone ^[2][8].
• Organ involvement: EGPA can affect the kidneys, heart, and gastrointestinal tract ^[8][9].

A Note on Medications: Treatments like oral corticosteroids or biologic asthma medications can significantly lower eosinophil counts and mask signs of inflammation ^[10]. Doctors often want to know your highest historical eosinophil count before these treatments started ^[3]. Please do not stop or alter any prescribed medications just to obtain a test unless directly instructed by your care team.

Telling EGPA Apart from GPA

GPA (Granulomatosis with Polyangiitis) is another ANCA-associated vasculitis. While EGPA and GPA can sometimes share overlapping symptoms, their typical patterns differ ^[3][4][11]:

• Asthma and Eosinophils: EGPA is heavily characterized by asthma and marked eosinophilia ^[3]. GPA patients rarely have asthma, and having very high eosinophils makes a GPA diagnosis less likely ^[4].
• Sinus and Lung Symptoms: EGPA often causes nasal polyps, chronic sinusitis, and transient lung infiltrates. GPA more commonly causes destructive sinonasal disease (such as damage to the nasal cartilage) and large nodules or cavities in the lungs ^[3][4][12].
• Antibody Types (ANCA): Blood tests for ANCA (antineutrophil cytoplasmic antibodies) are supportive tools, but they are not absolute ^[13]. Most GPA patients test positive for PR3-ANCA (proteinase 3) ^[5]. In contrast, up to 60% of EGPA patients are ANCA-negative. When they are positive, they usually have MPO-ANCA (myeloperoxidase) ^[7][5]. A negative ANCA test does not rule out either disease, and results must be carefully interpreted alongside your physical symptoms ^[13][11].

How Doctors Reach a Conclusion

To help categorize these diseases consistently in research, specialists use the 2022 ACR/EULAR classification criteria. In this scoring system, features like asthma and nasal polyps add points toward an EGPA classification, while testing positive for PR3-ANCA subtracts points ^[3]. However, these criteria are intended for use after a specialist has already confirmed vasculitis and excluded mimics; they are not a diagnostic calculator you can use at home ^[14].

When an affected area is safely accessible, a tissue biopsy (such as from the skin or a nerve) can provide strong supporting evidence of eosinophilic inflammation or vasculitis ^[7][15]. However, sampling errors are common—meaning the needle might simply miss the inflamed tissue. Because of this, a negative or inconclusive biopsy does not rule out EGPA ^[16]. Diagnosis remains a comprehensive clinical judgment made by a specialist.

When to Seek Urgent Care

Because EGPA can affect major organs, seek immediate medical attention if you experience:

• New, rapidly progressive weakness or numbness in a limb
• Chest pain, severe shortness of breath, or fainting
• Coughing up blood
• Severe abdominal pain or gastrointestinal bleeding
• Dark, tea-colored, or bloody urine